Nuplazid: Ph II CLARITY started

Acadia began the double-blind, placebo-controlled Phase II CLARITY trial to evaluate 34 mg oral Nuplazid once daily for 10 weeks plus ongoing antidepressant therapy in about 188 patients. CLARITY will...